| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 31 |
| 1 | PREDNISOLONE ORAL SOLUTION | 30 |
| 2 | PREDNISOLONE | 29 |
| 3 | PREDNISOLONE ORAL | 29 |
| 4 | METHOTREXATE | 28 |
| 5 | CYCLOSPORINE | 22 |
| 6 | ETOPOSIDE | 13 |
| 7 | ADALIMUMAB | 12 |
| 8 | ALEMTUZUMAB | 12 |
| 9 | MYCOPHENOLATE MOFETIL | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LULICONAZOLE | 1 | 0.0057 |
| 1 | EPCORITAMAB-BYSP | 6 | 0.0045 |
| 2 | LIFILEUCEL | 1 | 0.0035 |
| 3 | CEFPODOXIME PROXETIL | 2 | 0.0020 |
| 4 | PYRIMETHAMINE | 2 | 0.0016 |
| 5 | FOSPHENYTOIN SODIUM | 3 | 0.0012 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 9 | 0.0011 |
| 7 | DANTROLENE SODIUM | 1 | 0.0009 |
| 8 | ALDESLEUKIN | 1 | 0.0008 |
| 9 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 6 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 2 | 0.0016 |
| 1 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 6 | 0.0015 |
| 2 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 3 | Sulfonamide Antibacterial [EPC] | 3 | 0.0008 |
| 4 | CD30-directed Immunoconjugate [EPC] | 7 | 0.0007 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 12 | 0.0006 |
| 6 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 7 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 8 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 9 | Antimalarial [EPC] | 3 | 0.0003 |